Role of chest CT in staging of oropharyngeal cancer: A systematic review

Department of Oral and Maxillofacial Surgery, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY, England, UK.
Head & Neck (Impact Factor: 3.01). 04/2009; 31(4):548-55. DOI: 10.1002/hed.21004
Source: PubMed

ABSTRACT The prevalence of synchronous or metastatic tumors in patients with head and neck squamous cell carcinoma (HNSCC) ranges from 6% to 20% and has implications for prognosis and management of the primary disease. There is no consensus about the role of chest CT prior to definitive treatment patients with HNSCC.
A systematic review of all chest CT studies in relation to HNSCC was performed, together with a review of our local database.
Twenty-four studies were identified in addition to our local data. Prevalence of positive chest CT was 7.93%. Patients were significantly more likely to have a positive chest CT with N2 or N3 neck disease (p = .0062) and stage III or IV disease (p = .0001), and significantly less likely with tumors of the oral cavity (p = .0007).
We advocate chest CT as part of the initial investigations for patients with HNSCC.


Full-text (2 Sources)

Available from
May 21, 2014